PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40684393,Pharmacokinetics and Safety of Ripretinib in Participants with Hepatic Impairment: A PhaseÂ 1 Study.,2025,Anna Papinska; Lakshmi Viswanathan; Qiang Lu; Farida Abane; Charles Psoinos; Rodrigo Ruiz-Soto,"Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA. anna.papinska@deciphera.com.; Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA.; Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA.; Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA.; Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA.; Clinical Pharmacology, Deciphera Pharmaceuticals LLC, 200 Smith Street, Waltham, MA, 02451, USA.",Not found
40684139,Understanding barriers to breast screening: an online survey of non-attenders as part of a service evaluation in the breast screening programme in England.,2025,Sue Hudson,"Peel & Schriek Consulting Ltd, London, UK.",Not found
40681056,Low Dose-Averaged LET Contributes to Local Recurrence of Pancreatic Cancer Treated with Carbon Ion Radiotherapy.,2025,Hanae Yoshida,"Hitachi, Ltd. Research & Development Group, Kokubunji, Japan.",Not found
40680752,"Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.",2025,Angely Loubert; Laurine Bunod; Manal M'Hari,"Modus Outcomes, a THREAD Company, Lyon, France.; Modus Outcomes, a THREAD Company, Lyon, France.; Modus Outcomes, a THREAD Company, Lyon, France.",Not found
40679792,"MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies.",2025,Hun Seok Lee; Chae Rin Kim,"Cichlid Corporation, Seoul, Republic of Korea.; Abion Inc, Seoul, Republic of Korea.",Not found
